Camden National Bank’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.1M | Buy |
22,101
+36
| +0.2% | +$17.3K | 1.44% | 26 |
|
|
2026
Q1 | $10.8M | Sell |
22,065
-122
| -0.5% | -$66.2K | 1.47% | 25 |
|
|
2025
Q4 | $12.9M | Buy |
22,187
+56
| +0.3% | +$31.7K | 1.77% | 21 |
|
|
2025
Q3 | $10.7M | Buy |
22,131
+81
| +0.4% | +$37.7K | 1.5% | 27 |
|
|
2025
Q2 | $8.94M | Buy |
22,050
+7,934
| +56% | +$3.32M | 1.29% | 35 |
|
|
2025
Q1 | $7.02M | Buy |
14,116
+3,971
| +39% | +$2.15M | 1.04% | 48 |
|
|
2024
Q4 | $5.28M | Buy |
10,145
+40
| +0.4% | +$22K | 0.79% | 53 |
|
|
2024
Q3 | $6.25M | Sell |
10,105
-105
| -1% | -$62.2K | 0.9% | 52 |
|
|
2024
Q2 | $5.65M | Buy |
10,210
+1,126
| +12% | +$645K | 0.87% | 53 |
|
|
2024
Q1 | $5.28M | Sell |
9,084
-172
| -2% | -$96.5K | 0.93% | 51 |
|
|
2023
Q4 | $4.91M | Sell |
9,256
-57
| -0.6% | -$27.6K | 0.91% | 52 |
|
|
2023
Q3 | $4.71M | Buy |
9,313
+70
| +0.8% | +$37.3K | 0.97% | 52 |
|
|
2023
Q2 | $4.82M | Buy |
9,243
+1,991
| +27% | +$1.07M | 0.94% | 52 |
|
|
2023
Q1 | $4.18M | Buy |
7,252
+25
| +0.3% | +$14.1K | 0.85% | 57 |
|
|
2022
Q4 | $3.98M | Sell |
7,227
-140
| -2% | -$74.2K | 0.83% | 57 |
|
|
2022
Q3 | $3.74M | Buy |
7,367
+44
| +0.6% | +$24.6K | 0.83% | 57 |
|
|
2022
Q2 | $3.98M | Buy |
7,323
+53
| +0.7% | +$29.2K | 0.82% | 59 |
|
|
2022
Q1 | $4.29M | Buy |
7,270
+77
| +1% | +$44.2K | 0.78% | 59 |
|
|
2021
Q4 | $4.8M | Buy |
7,193
+11
| +0.2% | +$6.87K | 0.84% | 53 |
|
|
2021
Q3 | $4.1M | Buy |
7,182
+87
| +1% | +$47.8K | 0.79% | 54 |
|
|
2021
Q2 | $3.58M | Sell |
7,095
-82
| -1% | -$38.7K | 0.68% | 59 |
|
|
2021
Q1 | $3.27M | Buy |
7,177
+121
| +2% | +$57.8K | 0.65% | 59 |
|
|
2020
Q4 | $3.29M | Sell |
7,056
-175
| -2% | -$82.1K | 0.68% | 57 |
|
|
2020
Q3 | $3.19M | Buy |
7,231
+81
| +1% | +$33.5K | 0.7% | 51 |
|
|
2020
Q2 | $2.59M | Buy |
7,150
+6,096
| +578% | +$2.04M | 0.64% | 50 |
|
|
2020
Q1 | $299K | Buy |
1,054
+156
| +17% | +$49.2K | 0.08% | 96 |
|
|
2019
Q4 | $292K | Buy |
898
+124
| +16% | +$37.6K | 0.06% | 110 |
|
|
2019
Q3 | $225K | Buy |
774
+60
| +8% | +$17.2K | 0.05% | 113 |
|
|
2019
Q2 | $210K | Sell |
714
-50
| -7% | -$13.8K | 0.05% | 112 |
|
|
2019
Q1 | $209K | Buy |
+764
| New | +$190K | 0.05% | 107 |
|
|
2018
Q4 | – | Sell |
-937
| Closed | -$229K | – | 112 |
|
|
2018
Q3 | $229K | Sell |
937
-314
| -25% | -$72.2K | 0.06% | 99 |
|
|
2018
Q2 | $259K | Sell |
1,251
-127
| -9% | -$27K | 0.07% | 95 |
|
|
2018
Q1 | $285K | Buy |
+1,378
| New | +$289K | 0.08% | 77 |
|
Other funds holding TMO
RG
ECSS
LT
Camden National Bank's TMO Position: Q2 2026 in Review
Camden National Bank increased its Thermo Fisher Scientific (TMO) stake by 0.16% in Q2 2026, buying an estimated $17.3K and bringing the position to 22,101 shares worth $11.1M. The position accounts for 1.44% of the portfolio, ranked #26.
Camden National Bank first reported a position in TMO in Q1 2018 and has held it in 33 quarters since. The position peaked at $12.9M in Q4 2025. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Camden National Bank held 22,101 shares of Thermo Fisher Scientific worth $11.1M as of Q2 2026.
- Camden National Bank bought 36 Thermo Fisher Scientific shares in Q2 2026, an estimated $17.3K.
- Thermo Fisher Scientific made up 1.44% of Camden National Bank's portfolio in Q2 2026, its #26 holding.
- Camden National Bank first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 33 quarters since.
- Camden National Bank's Thermo Fisher Scientific position peaked at $12.9M in Q4 2025.
- 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Camden National Bank's 13F filing for Q2 2026, filed 31 Jul 2026.